Guobin Chen

6PUBLICATIONS
4CO-AUTHORS
Predictive and prognostic markersHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 15, 2026
Post-Treatment Prognostic Nutritional Index Outperforms Baseline Index as an Independent Prognostic Biomarker in Advanced Hepatocellular Carcinoma Receiving Immune-Based Systemic Therapy.

|Apr 21, 2025
A Novel Nomogram Model for Predicting the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Infection.

Yanfang Wu, Meixia Wang, Zhenzhen Zhang

|Oct 27, 2022
Hepatic Arterial Infusion Chemotherapy with Oxaliplatin Plus Raltitrexed as an Alternative Option in Advanced Hepatocellular Carcinoma Patients with Failure of, or Unsuitability for, Transarterial Chemoembolization.

Yanfang Wu, Susu Zheng, Zhenzhen Zhang

|Aug 26, 2022
Recurrence Outcome in Hepatocellular Carcinoma within Milan Criteria Undergoing Microwave Ablation with or without Transarterial Chemoembolization.

Guobin Chen, Hong Chen, Xing Huang

|Aug 12, 2022
Efficacy of Transarterial Chemoembolization Combined with Molecular Targeted Agents for Unresectable Hepatocellular Carcinoma: A Network Meta-Analysis.

Zhenzhen Zhang, Yanfang Wu, Tanghui Zheng

|Feb 24, 2022
Prognostic Significance of Tumor Growth Rate (TGR) in Patients with Huge Hepatocellular Carcinoma Undergoing Transcatheter Arterial Chemoembolization.

Guobin Chen, Xiaoying Xie, Meixia Wang

Pageof 1

Frequent Collaborators

3 joint publications

Zhenzhen Zhang

2 joint publications

Meixia Wang

1 joint publications

Yanfang Wu

1 joint publications

Hong Chen